LANTUS (Insulin glargine) drug information from MPR

Links shared publicly online about this topic.

  • 347
    total visits

LANTUS (Insulin glargine) drug information from MPR

empr.com

LANTUS (Insulin glargine) drug information for Diabetes mellitus~hyperglycemic agents from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.

View full resource at empr.com

Tags: Diabetes Type 1 Medication, Diabetes Type 2 Medication, Diabetes Medication, Insulin, Drug, Lantus, News

  • Share

Most Recently Shared on April 22, 2011 at 4:28 am By:

eMPR MPR

MPR News: LANTUS: How supplied: OptiClik cartridge system discontinued. http://bit.ly/hm6Z3B

1 year ago...

Lantus and Cancer: Further Study Needed :: Diabetes Self-Management

diabetesselfmanagement.com — “Late last week, results from several european studies showing a possible link between lantus (insulin glargine) and cancer were published online in the journal diabetologia. health agencies such as the u.s. food and drug administration (fda) and the international diabetes federation (idf) have been swift in their response to the release of this information, indicating that the studies are not conclusive and that people with diabetes should not stop taking lantus without speaking to their doctorsView full resource at diabetesselfmanagement.com

  • View Related
  • Share

Most Recently Shared on July 1, 2009 at 7:23 pm By:

ManageDiabetes Diabetes Self-Mgmt Health Site

#diabetes New Blog post by Diane Fennell: Lantus and Cancer: Further Study Needed http://bit.ly/3ZXIL

3 years ago...

Advertisement